1. Home
  2. NOTV

as 07-26-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Founded: 1974 Country:
United States
United States
Employees: N/A City: WEST LAFAYETTE
Market Cap: 46.2M IPO Year: 1997
Target Price: $5.25 AVG Volume (30 days): 238.8K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.77 EPS Growth: N/A
52 Week Low/High: $1.51 - $11.42 Next Earning Date: 08-08-2024
Revenue: $552,744,000 Revenue Growth: -7.47%
Revenue Growth (this year): -9.67% Revenue Growth (next year): 6.02%

NOTV Daily Stock ML Predictions

Stock Insider Trading Activity of Inotiv Inc. (NOTV)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Garrett Michael NOTV Chief Commercial Officer Dec 14 '23 Buy $2.83 5,000 $14,145.00 16,467 SEC Form 4
Beattie John Gregory NOTV Chief Operating Officer Dec 14 '23 Buy $3.12 47,966 $149,836.19 111,761 SEC Form 4
Leasure Robert Jr. NOTV President and CEO Jun 7 '19 Buy $1.98 7,500 $14,864.25 105,000 SEC Form 4

Share on Social Networks: